Victoria's Secret on Tuesday disclosed that it detected a security incident relating to information technology systems, which ...

WASHINGTON (Reuters) - The U.S. Federal Reserve announced on Tuesday that Wells Fargo will no longer have to operate under a ...

In a landmark move to bolster Africa's intellectual property ecosystem, the Registrar General of The Gambia's Ministry of Justice on Monday launched a five-day Activity 9 Patent Drafting Training for ...

OXB (LSE: OXB) ("the Company”), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch ...

You may have seen it in the news recently: a baby in Pennsylvania with a rare genetic disorder was healed with a personalized ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

A 32-year-old woman presented to our emergency department 2 days after the onset of bilateral hand swelling. Two weeks earlier, her 8-year-old son had had an erythematous rash on both cheeks. A week ...

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene ...

Editas Medicine, Inc. (EDIT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home page ...

Option Chain is currently not available. Nasdaq provides call and put options information of stocks. Financial analysts and individual investors can rely on the chain to gauge the stock's ...

Option Chain is currently not available. Nasdaq provides call and put options information of stocks. Financial analysts and individual investors can rely on the chain to gauge the stock's ...

The Artemis programme and others aim to send humans to the Moon and, eventually, to Mars. Innovations in health care that support the mission crew could also benefit people at home.